Aethlon Medical Inc (AEMD) stock
AEMDNasdaqPharmaceutical PreparationsFiscal year ends March 31
$5.11+0.03 (+0.59%)
Close on Nov 18, 2026Market cap $3.63MP/E –Yield –
Earnings
Aethlon Medical's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Next report
Feb 11, 2027
Q3 FY2027 · estimated, after the close
Revenue, Q2 FY2027
–
EPS, Q2 FY2027
-$2.60
Latest guidance
None
No outlook given in releases
Quarterly results
Revenue and earnings per share from each of Aethlon Medical's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Source |
|---|---|---|---|---|---|
| Q3 FY2027ended Dec 31, 2026 | Feb 11, 2027Expected | – | – | – | – |
| Q2 FY2027ended Sep 30, 2026 | Nov 12, 2026after the close | – | – | -$2.60 | Release |
| Q1 FY2027ended Jun 30, 2026 | Aug 13, 2026after the close | – | – | – | Release |
| Q4 FY2026ended Mar 31, 2026 | Jun 10, 2026after the close | – | – | – | Release |
| Q3 FY2026ended Dec 31, 2025 | Feb 12, 2026after the close | – | – | – | Release |
| Q1 FY2026ended Jun 30, 2025 | Aug 13, 2025after the close | – | – | – | Release |
| Q4 FY2025ended Mar 31, 2025 | Jun 27, 2025during market hours | – | – | – | Release |
| Q3 FY2025ended Dec 31, 2024 | Feb 12, 2025after the close | – | – | -$0.13 | Release |
| Q2 FY2025ended Sep 30, 2024 | Nov 13, 2024after the close | – | – | -$0.20 | Release |
| Q1 FY2025ended Jun 30, 2024 | Aug 14, 2024after the close | – | – | -$0.34 | Release |
| Q4 FY2024ended Mar 31, 2024 | Jun 27, 2024after the close | – | – | – | Release |
| Q3 FY2024ended Dec 31, 2023 | Feb 14, 2024after the close | – | – | -$1.37 | Release |
| Q2 FY2024ended Sep 30, 2023 | Nov 14, 2023after the close | – | – | -$1.22 | Release |
| Q1 FY2024ended Jun 30, 2023 | Aug 10, 2023after the close | – | – | -$0.14 | Release |
| Q4 FY2023ended Mar 31, 2023 | Jun 28, 2023after the close | – | – | – | Release |
| Q3 FY2023ended Dec 31, 2022 | Feb 13, 2023after the close | – | – | -$0.12 | Release |
| Q2 FY2023ended Sep 30, 2022 | Nov 14, 2022after the close | – | – | -$0.18 | Release |
| Q1 FY2023ended Jun 30, 2022 | Aug 9, 2022after the close | – | – | -$0.19 | Release |
| Q4 FY2022ended Mar 31, 2022 | Jun 28, 2022after the close | – | – | – | Release |
| Q3 FY2022ended Dec 31, 2021 | Feb 14, 2022after the close | $17.00K | – | -$0.16 | Release |
| Q2 FY2022ended Sep 30, 2021 | Nov 9, 2021after the close | $132.00K | – | -$0.13 | Release |
| Q1 FY2022ended Jun 30, 2021 | Aug 9, 2021after the close | – | – | – | Filing |
| Q4 FY2021ended Mar 31, 2021 | Jun 24, 2021after the close | – | – | – | Filing |
| Q3 FY2021ended Dec 31, 2020 | Feb 10, 2021after the close | – | – | – | Filing |
| Q2 FY2021ended Sep 30, 2020 | Oct 28, 2020after the close | – | – | – | Filing |
| Q1 FY2021ended Jun 30, 2020 | Aug 11, 2020after the close | – | – | – | Filing |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Guidance
Aethlon Medical has not given guidance in its releases
Many companies give their outlook only on the conference call or not at all. When Aethlon Medical puts a forecast in an earnings release, it is listed here with the exact sentence.
Press releases
Releases Aethlon Medical filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Update
- Update
- Results
- Medical Announces Pricing of $4.0 Million Follow-On Offering Priced At-The-Market Under NASDAQ RulesNews
- Results
- Results
- Update
- Results
- News
- Update
- Results
- Results
- Results
- News
See a number that looks wrong?